Novel hydroxyphosphonate inhibitors of CD-45 tyrosine phosphatase
摘要:
CD-45 tyrosine phosphatase [E.C. 3.1.3.48] is an important player in the regulation of cell activation and proliferation in hematopoetic cells. As part of a program in immune response modulation, we prepared the first series of small organic molecule inhibitors of CD-45. The preparation and in vitro screening of these hydroxyphosphonates is described herein. (C) 1997 Elsevier Science Ltd.
Phospho sulfonic acid: an efficient and recyclable solid acid catalyst for the solvent-free synthesis of α-hydroxyphosphonates and their anticancer properties
Nitroarylhydroxymethylphosphonic acids as inhibitors of CD45
作者:Scott A. Beers、Elizabeth A. Malloy、Wei Wu、Michael P. Wachter、Uma Gunnia、Druie Cavender、Crafford Harris、Janet Davis、Ruth Brosius、J.Lee Pellegrino-Gensey、John Siekierka
DOI:10.1016/s0968-0896(97)00174-0
日期:1997.12
A series of nitroarylhydroxymethylphosphonic acids was synthesized and evaluated as inhibitors of CD45. It was discovered that both the alpha hydroxy and nitro groups are essential for activity. Potency is enhanced by the addition of a large lipophilic group on the aryl ring adjacent to the phosphonic acid moiety. Kinetics studies have shown that these compounds are competitive inhibitors and thus bind at the active site of this enzyme. (C) 1997 Elsevier Science Ltd.
Phospho sulfonic acid: an efficient and recyclable solid acid catalyst for the solvent-free synthesis of α-hydroxyphosphonates and their anticancer properties
作者:Reddi Mohan Naidu Kalla、Hye Ri Lee、Jiafu Cao、Jin-Wook Yoo、Il Kim
DOI:10.1039/c5nj00312a
日期:——
Some of the title compounds synthesized by a green protocol showed potent anticancer activity.
一些由绿色合成方法合成的化合物显示出强大的抗癌活性。
Novel hydroxyphosphonate inhibitors of CD-45 tyrosine phosphatase
作者:Roger F. Frechette、Caridad Ackerman、Scott Beers、Rich Look、John Moore
DOI:10.1016/s0960-894x(97)00390-9
日期:1997.9
CD-45 tyrosine phosphatase [E.C. 3.1.3.48] is an important player in the regulation of cell activation and proliferation in hematopoetic cells. As part of a program in immune response modulation, we prepared the first series of small organic molecule inhibitors of CD-45. The preparation and in vitro screening of these hydroxyphosphonates is described herein. (C) 1997 Elsevier Science Ltd.